145 related articles for article (PubMed ID: 7654464)
1. Decreased bone turnover in oral contraceptive users.
Garnero P; Sornay-Rendu E; Delmas PD
Bone; 1995 May; 16(5):499-503. PubMed ID: 7654464
[TBL] [Abstract][Full Text] [Related]
2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
3. Associations of oral contraceptive use and dietary restraint with bone speed of sound and bone turnover in university-aged women.
Di Giovanni G; Roy BD; Gammage KL; Mack D; Klentrou P
Appl Physiol Nutr Metab; 2008 Aug; 33(4):696-705. PubMed ID: 18641712
[TBL] [Abstract][Full Text] [Related]
4. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence.
Cibula D; Skrenkova J; Hill M; Stepan JJ
Eur J Endocrinol; 2012 Jun; 166(6):1003-11. PubMed ID: 22436400
[TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
6. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
Paoletti AM; Orrù M; Floris S; Mannias M; Vacca AM; Ajossa S; Guerriero S; Melis GB
Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
[TBL] [Abstract][Full Text] [Related]
7. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.
Mais V; Fruzzetti F; Ajossa S; Paoletti AM; Guerriero S; Melis GB
Contraception; 1993 Nov; 48(5):445-52. PubMed ID: 8275694
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and bone mineral density: A population-based study.
Pasco JA; Kotowicz MA; Henry MJ; Panahi S; Seeman E; Nicholson GC
Am J Obstet Gynecol; 2000 Feb; 182(2):265-9. PubMed ID: 10694322
[TBL] [Abstract][Full Text] [Related]
9. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
10. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
11. Sexual differences in bone markers and bone mineral density of normal Chinese.
Tsai KS; Pan WH; Hsu SH; Cheng WC; Chen CK; Chieng PU; Yang RS; Twu ST
Calcif Tissue Int; 1996 Dec; 59(6):454-60. PubMed ID: 8939771
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys.
Register TC; Jayo MJ; Jerome CP
Osteoporos Int; 1997; 7(4):348-53. PubMed ID: 9373569
[TBL] [Abstract][Full Text] [Related]
15. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity.
Hartard M; Bottermann P; Bartenstein P; Jeschke D; Schwaiger M
Contraception; 1997 Feb; 55(2):87-90. PubMed ID: 9071517
[TBL] [Abstract][Full Text] [Related]
16. Bone mass and long-term monophasic oral contraceptive treatment in young women.
Polatti F; Perotti F; Filippa N; Gallina D; Nappi RE
Contraception; 1995 Apr; 51(4):221-4. PubMed ID: 7796586
[TBL] [Abstract][Full Text] [Related]
17. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
18. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Vescovi JD; VanHeest JL; De Souza MJ
Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
[TBL] [Abstract][Full Text] [Related]
19. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
20. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
